Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

238
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
238
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

442
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
442
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

345
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
345

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Role of Pharmacogenomics Studies for Precision Medicine Among Ethiopian Patients and Their Clinical Implications: A Scoping Review.

Pharmacogenomics and personalized medicine·2024
Same author

Antimicrobial use-related drug therapy problems and associated factors among patients in the medical ward of Wachemo University Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Southwest Ethiopia.

SAGE open medicine·2022
Same author

Constitutive androstane receptor and pregnane X receptor genotype influence efavirenz plasma concentration and CYP2B6 enzyme activity.

Scientific reports·2022
Same author

Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.

Omics : a journal of integrative biology·2017
Same author

<i>HLA-B</i><sup>*</sup><i>57</i> Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians.

Frontiers in pharmacology·2017
Same author

Genome-Wide Association Studies for Idiosyncratic Drug-Induced Hepatotoxicity: Looking Back-Looking Forward to Next-Generation Innovation.

Omics : a journal of integrative biology·2017

相关实验视频

Updated: Sep 10, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

埃塞俄比亚中部结核病患者的抗结核药物诱导肝损伤

Zelalem Petros1,2, Anteneh Tamirat3, Wondimu Assefa4

  • 1Department of Pharmacy, College of Medicine and Health Sciences, Wachemo University, Hosaina, Ethiopia. zelalemp@yahoo.com.

Scientific reports
|August 25, 2025
PubMed
概括

埃塞俄比亚的一项研究发现,16%的结核病患者患有抗结核药物诱导的肝损伤 (ATDILI). 女性性别,年龄较大,低BMI和艾滋病毒阳性是ATDILI的重要预测因素.

关键词:
抗结核药物中部埃塞俄比亚药物引起的肝损伤霍萨纳

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K

相关实验视频

Last Updated: Sep 10, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K

科学领域:

  • 肝病学
  • 传染性疾病
  • 药物监督管理

背景情况:

  • 用抗结核药物治疗结核病可显著降低死亡率.
  • 然而,抗结核药物可能会导致肝损伤 (ATDILI),导致患病率增加和药物耐药性等并发症.
  • 关于ATDILI的患病率和预测因素的数据有限.

研究的目的:

  • 评估埃塞俄比亚中部霍萨纳镇的结核病患者中ATDILI的患病率.
  • 确定与ATDILI相关的预测因子和临床特征.
  • 为结核病患者提供ATDILI的监测策略.

主要方法:

  • 一项前性队列研究,涉及219名新诊断的结核病患者,接受一线抗结核药物治疗.
  • 肝功能测试在治疗开始时,治疗4周和8周进行.
  • 已经存在肝脏异常或病毒性肝炎的患者被排除在外.

主要成果:

  • 在219名参与者中,ATDILI的患病率为16. 0% (35).
  • 在5. 7%的受影响患者中发生严重的ATDILI.
  • 重要预测因素包括女性性别 (AOR=2. 57),年龄较大 (AOR=1. 05),低体重指数 (AOR=0. 81) 和艾滋病毒阳性 (AOR=6. 73).

结论:

  • 在埃塞俄比亚中部的霍萨纳镇, 结核病患者中患有大量的ATDILI.
  • 女性,老年人,体重不足和艾滋病毒阳性结核病患者的ATDILI风险更高.
  • 对于这些高危人群来说,定期监测肝功能对于缓解ATDILI至关重要.